Guardant Health GH
$145.83 +$0.24 (+0.16%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $145.83 0.00%
Open$143.10
Prev close$145.59
Day range$141.01 – $148.27
Volume2.76M
Market cap$19.73B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$360.98M+36.1% YoY
Operating profit-$132.77M-34.1% YoY
Net profit-$124.36M-34.1% YoY
Diluted EPS-$0.93-25.7% YoY
Free cash flow-$37.19M+18.7% YoY
Operating cash flow-$23.71M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin65.2%
Operating margin-39.4%
Net margin-37.9%
Return on assets-30.7%
Current ratio3.60
Liabilities / assets114.6%
Cash & investments$1.03B
Total debt$1.66B
Net cash (debt)-$635.79M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $360.98M | $334.98M | $301.67M | $982.02M | $281.27M |
| Total Operating Revenue | $360.98M | $334.98M | $301.67M | $982.02M | $281.27M |
| Cost of Revenue | $124.82M | $115.95M | $104.92M | $349.01M | $99.49M |
| Gross Profit | $236.15M | $219.03M | $196.75M | $633.01M | $181.77M |
| Operating Expense | $368.92M | $348.15M | $318.10M | $1.07B | $302.58M |
| Selling and Admin Expenses | $268.08M | $251.61M | $227.06M | $706.07M | $204.32M |
| -Selling & Marketing Expense | $177.22M | $189.95M | $169.13M | $494.66M | $143.38M |
| -General & Admin Expense | $90.86M | $61.66M | $57.93M | $211.41M | $60.93M |
| Research & Development | $100.84M | $96.53M | $91.04M | $364.19M | $98.26M |
| Operating Profit | -$132.77M | -$129.12M | -$121.35M | -$437.25M | -$120.81M |
| Net Non-Operating Interest Income (Expense) | $8.40M | $8.85M | $9.80M | $30.20M | $8.85M |
| Non-Operating Interest Income | $9.75M | $10.20M | $11.15M | $34.10M | $10.03M |
| Non-Operating Interest Expense | $1.35M | $1.35M | $1.35M | $3.90M | $1.18M |
| Other Income (Expense) | $342,000.00 | $308,000.00 | -$157,000.00 | -$10.49M | -$18.27M |
| Other Non-Operating Income (Expenses) | $342,000.00 | $308,000.00 | -$157,000.00 | -$10.49M | -$18.27M |
| Pretax Profit | -$124.02M | -$119.96M | -$111.70M | -$417.54M | -$130.22M |
| Tax | $343,000.00 | $185,000.00 | $372,000.00 | -$1.26M | -$1.73M |
| Net Profit | -$124.36M | -$120.14M | -$112.08M | -$416.28M | -$128.49M |
| Profit from Continuing Operations | -$124.36M | -$120.14M | -$112.08M | -$416.28M | -$128.49M |
| Net Income to Parent Company | -$124.36M | -$120.14M | -$112.08M | -$416.28M | -$128.49M |
| Net Income to Common Stockholders | -$124.36M | -$120.14M | -$112.08M | -$416.28M | -$128.49M |
| Basic EPS | -$0.93 | -$0.90 | -$0.85 | -$3.32 | -$1.00 |
| Diluted EPS | -$0.93 | -$0.90 | -$0.85 | -$3.32 | -$1.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.89B | $1.91B | $1.92B | $2.01B | $2.01B |
| Total Current Assets | $1.34B | $1.36B | $1.37B | $1.47B | $1.47B |
| Cash and Cash Equivalents & Short-Term Investments | $1.03B | $1.05B | $1.10B | $1.20B | $1.20B |
| -Cash and Cash Equivalents | $1.03B | $1.05B | $989.29M | $378.20M | $378.20M |
| -Short Term Investments | $0.00 | $0.00 | $113.47M | $823.40M | $823.40M |
| Receivables | $186.55M | $144.25M | $137.40M | $137.85M | $137.85M |
| -Accounts Receivable | $180.15M | $140.15M | $131.20M | $132.65M | $132.65M |
| -Other Receivables | $6.40M | $4.10M | $6.20M | $5.20M | $5.20M |
| Inventory | $93.49M | $105.46M | $83.85M | $85.88M | $85.88M |
| Other Current Assets | $36.52M | $61.46M | $43.49M | $40.72M | $40.72M |
| Total Non-Current Assets | $542.24M | $547.66M | $547.79M | $547.61M | $547.61M |
| Net PPE | $292.72M | $302.87M | $303.94M | $304.76M | $304.76M |
| -Gross PPE | $516.99M | $517.24M | $508.94M | $503.67M | $503.67M |
| -Accumulated Depreciation | -$224.27M | -$214.37M | -$205.00M | -$198.90M | -$198.90M |
| Goodwill and Other Intangible Assets | $102.25M | $102.52M | $102.80M | $103.18M | $103.18M |
| -Goodwill | $77.26M | $77.26M | $77.26M | $77.26M | $77.26M |
| -Other Intangible Assets | $24.99M | $25.27M | $25.54M | $25.92M | $25.92M |
| Other Non-Current Assets | $147.27M | $142.27M | $141.05M | $139.67M | $139.67M |
| Total Liabilities | $2.16B | $2.14B | $2.10B | $2.11B | $2.11B |
| Total Current Liabilities | $373.17M | $338.96M | $292.15M | $302.73M | $302.73M |
| Payables | $102.51M | $93.51M | $75.03M | $54.44M | $54.44M |
| -Accounts Payable | $102.51M | $93.51M | $75.03M | $54.44M | $54.44M |
| Current Accrued Expenses | $76.13M | $51.53M | $49.98M | $50.21M | $50.21M |
| Short-Term Debt and Capital Lease Obligation | $28.80M | $27.76M | $28.03M | $27.68M | $27.68M |
| -Current Capital Lease Obligation | $28.80M | $27.76M | $28.03M | $27.68M | $27.68M |
| Current Deferred Liabilities | $38.10M | $44.79M | $47.77M | $50.75M | $50.75M |
| Total Non-Current Liabilities | $1.79B | $1.80B | $1.80B | $1.81B | $1.81B |
| Long Term Debt and Capital Lease Obligation | $1.66B | $1.67B | $1.68B | $1.68B | $1.68B |
| -Long Term Debt | $1.50B | $1.50B | $1.50B | $1.50B | $1.50B |
| -Long Term Capital Lease Obligation | $160.22M | $166.31M | $173.06M | $178.46M | $178.46M |
| Other Non-Current Liabilities | $125.75M | $126.94M | $127.69M | $127.77M | $127.77M |
| Total Equity | -$275.90M | -$222.87M | -$181.07M | -$99.31M | -$99.31M |
| Stockholders' Equity | -$275.90M | -$222.87M | -$181.07M | -$99.31M | -$99.31M |
| Capital Stock | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -Common Stock | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $3.08B | $3.01B | $2.93B | $2.90B | $2.90B |
| Retained Earnings | -$3.35B | -$3.23B | -$3.11B | -$2.99B | -$2.99B |
| Gains/Losses Not Affecting Retained Earnings | -$5.13M | -$5.56M | -$5.15M | -$4.85M | -$4.85M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$23.71M | -$57.78M | -$65.62M | -$184.76M | -$26.37M |
| Net cash flow from continuing operations | -$23.71M | -$57.78M | -$65.62M | -$184.76M | -$26.37M |
| Net Income from Continuing Operations | -$124.36M | -$120.14M | -$112.08M | -$416.28M | -$128.49M |
| Depreciation & Depletion & Amortization | $10.18M | $9.56M | $9.44M | $39.74M | $10.05M |
| Other Non-Cash Items | $7.07M | $10.33M | $19.66M | $40.96M | $8.09M |
| Change in Working Capital | $20.97M | -$14.26M | -$23.27M | -$14.43M | $32.29M |
| -Change in Receivables | -$42.46M | -$6.89M | $942,000.00 | -$28.18M | -$22.20M |
| -Change in Inventory | $11.97M | -$21.61M | $2.03M | -$14.79M | $4.61M |
| -Change in Prepaid Assets | $23.87M | -$16.96M | -$7.24M | -$6.35M | $2.25M |
| -Change in Payables and Accrued Expense | $41.71M | $44.29M | -$8.23M | $52.75M | $53.75M |
| -Change in Other Current Assets | -$119,000.00 | $899,000.00 | $1.06M | $212,000.00 | -$567,000.00 |
| -Change in Other Current Liabilities | -$7.12M | -$9.26M | -$8.60M | -$37.52M | -$9.50M |
| -Change In Other Working Capital | -$6.89M | -$4.73M | -$3.23M | $19.46M | $3.95M |
| Net cash flow from investing | -$13.48M | $101.47M | $699.42M | -$627.20M | -$905.07M |
| Net Cash Flow from Continuing Investing Activities | -$13.48M | $101.47M | $699.42M | -$627.20M | -$905.07M |
| Net PPE Purchase and Sale | -$13.48M | -$11.76M | -$5.58M | -$48.31M | -$27.85M |
| Net Investment Purchase and Sale | $0.00 | $113.23M | $705.00M | -$519.91M | -$818.23M |
| Financing Cash Flow | $15.01M | $23.01M | -$21.58M | $671.13M | $732.03M |
| Net Cash Flow from Continuing Financing Activities | $15.01M | $23.01M | -$21.58M | $671.13M | $732.03M |
| Net Issuance Payments Of Debt | $1.43M | -$1.43M | $0.00 | $402.50M | $397.47M |
| Net Common Stock Issuance | $0.00 | $0.00 | $0.00 | $299.99M | $345.00M |
| Proceeds from Stock Option Exercised | $19.36M | $28.29M | $3.65M | $32.81M | $19.08M |
| Net Other Financing Charges | -$5.77M | -$3.84M | -$25.23M | -$64.17M | -$29.52M |
| Ending Cash Balance | $1.15B | $1.17B | $1.10B | $489.42M | $489.42M |
| Net Change in Cash | -$22.17M | $66.71M | $612.22M | -$140.83M | -$199.41M |
| Beginning Cash Balance | $1.17B | $1.10B | $489.42M | $629.76M | $689.52M |
| Effect of Exchange Rate Changes | $440,000.00 | -$411,000.00 | -$194,000.00 | $491,000.00 | -$686,000.00 |
| Free Cash Flow | -$37.19M | -$69.54M | -$71.20M | -$233.07M | -$54.22M |
| Gain/Loss from Continuing Operations | – | – | – | -$13.67M | $0.00 |
| Net Business Purchase and Sale | – | – | – | -$58.99M | – |
No comments yet — be the first to weigh in on GH.
Sign in to join the discussion.